Tower Research Capital (TRC)’s MedTech Acquisition Corporation Unit MTACU Stock Holding History

Tower Research Capital (TRC)’s Portfolio MTACU Stock Details MTACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-128	Closed	-$1.32K	–	6440
2023 Q2	$1.32K	Sell	128 -87	-40%	-$894	﹤0.01%	5407
2023 Q1	$2K	Hold	215	–	–	﹤0.01%	5453
2022 Q4	$2K	Hold	215	–	–	﹤0.01%	5489
2022 Q3	$2K	Hold	215	–	–	﹤0.01%	5668
2022 Q2	$2K	Hold	215	–	–	﹤0.01%	5656
2022 Q1	$2K	Hold	215	–	–	﹤0.01%	5663
2021 Q4	$2K	Hold	215	–	–	﹤0.01%	5720
2021 Q3	$2K	Buy	215 +115	+115%	+$1.16K	﹤0.01%	5343
2021 Q2	$1K	Buy	+100	New	+$1.01K	﹤0.01%	5306

Tower Research Capital (TRC)'s MTACU Position: Q3 2023 in Review

Tower Research Capital (TRC) sold out of MedTech Acquisition Corporation Unit (MTACU) in Q3 2023, closing a stake of 128 shares — an estimated $1.32K sold.

Tower Research Capital (TRC) first reported a position in MTACU in Q2 2021 and held it in 9 quarters. The position peaked at $2K in Q1 2023. 0 funds tracked by Wall St. Rank hold MTACU as of Q3 2023.

Tower Research Capital (TRC) reported no remaining MedTech Acquisition Corporation Unit position as of Q3 2023 after selling out during the quarter.
Tower Research Capital (TRC) sold 128 MedTech Acquisition Corporation Unit shares in Q3 2023, an estimated $1.32K.
Tower Research Capital (TRC) first reported a position in MedTech Acquisition Corporation Unit in Q2 2021 and held it in 9 quarters.
Tower Research Capital (TRC)'s MedTech Acquisition Corporation Unit position peaked at $2K in Q1 2023.
0 funds tracked by Wall St. Rank held MedTech Acquisition Corporation Unit as of Q3 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2023, filed 14 Nov 2023.